|
|
Volumn 15, Issue 11, 2016, Pages 735-737
|
|
Cancer metabolism pipeline breaks new ground
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 HYDROXYGLUTARIC ACID;
2 OXOGLUTARIC ACID;
ANTINEOPLASTIC AGENT;
CB 1158;
CB 839;
CPI 444;
ENASIDENIB;
EPACADOSTAT;
EVEROLIMUS;
FATTY ACID SYNTHASE;
GLUCOSE;
GLUTAMINASE;
GLUTAMINE;
INDOLEAMINE 2,3 DIOXYGENASE;
ISOCITRATE DEHYDROGENASE 2;
MONOCARBOXYLATE TRANSPORTER 1;
NIVOLUMAB;
PACLITAXEL;
PYRUVATE KINASE;
UNCLASSIFIED DRUG;
AG-221;
AMINOPYRIDINE DERIVATIVE;
TRIAZINE DERIVATIVE;
ACUTE MYELOBLASTIC LEUKEMIA;
AMINO ACID METABOLISM;
ARTICLE;
CANCER CELL;
DRUG SCREENING;
GAIN OF FUNCTION MUTATION;
GENE DELETION;
HUMAN;
KIDNEY CARCINOMA;
LOSS OF FUNCTION MUTATION;
MELANOMA;
METABOLISM;
NEOPLASM;
NON SMALL CELL LUNG CANCER;
NONHUMAN;
PRIORITY JOURNAL;
T LYMPHOCYTE;
TRIPLE NEGATIVE BREAST CANCER;
TUMOR MICROENVIRONMENT;
DRUG APPROVAL;
DRUG DEVELOPMENT;
DRUG EFFECTS;
DRUG INDUSTRY;
NEOPLASMS;
AMINOPYRIDINES;
ANTINEOPLASTIC AGENTS;
DRUG APPROVAL;
DRUG DISCOVERY;
DRUG INDUSTRY;
HUMANS;
METABOLIC NETWORKS AND PATHWAYS;
NEOPLASMS;
TRIAZINES;
|
|
EID: 84994336739
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd.2016.223 Document Type: Article |
|
Times cited : (36)
|
|
References (0)
|